Mikhail Blagosklonny, a renowned doctor, scientist, and biologist specializing in oncology and the field of anti-aging research and medicine. He earned his Ph.D. in Experimental Medicine and Cardiology from St. Petersburg’s First Pavlov State Medical University. He also previously received his master’s degree in Internal Medicine from the same institution.
Over the years, Mikhail has enjoyed a long and prolific career in cancer and anti-aging research. He began his work at the NY Medical College as an Associate Professor of Medicine in 2002.After this, Blagosklonny was appointed lead Scientist at New York’s Ordway Research Institute. View Mikhail’s profile in LinkedIn
After he left the institution, he was tapped to be the Oncology professor at the Roswell Park Cancer Institute in 2009, a position he still holds today.
Blagosklonny’s work is focused on cancer, mainly researching guided therapy techniques that prevent damage to healthy cells. He is also well-known for his research into the fundamental processes of aging, as well as anti-aging drug therapies.
He is particularly known for his hypothesis regarding the role of Target Of Rapamycin signaling in cancer and aging. Blagosklonny’s work in this theory has received wide acclaim, mainly because it suggests headway in discovering a cure for cancer and ensuring longevity in humans. His hypothesis widely suggests the use of popular anti-aging and cancer drug Rapamycin.
Apart from his teaching and research work at Roswell Park, Blagosklonny spends most of his time these days writing and editing peer review journals, especially for cancer and longevity-related tomes. He currently serves as chief editor at the publications Oncotarget, Aging – which deals with research into aging, senescence, gerontology, and molecular mechanics -and Cell Cycle. He is also the Associate Editor at Cancer Biology and Therapy, as well as serving on the panel of the Cell Death &Differentiation publication’s editorial board.
Mikhail Blagosklonny is a published author, with more than 200 papers published in peer-reviewed journals, with over 20,000 citations to his name. Many of his papers detail research into the subjects of cancer cell cycles, tumor suppression, signal transduction, and aging and longevity.
He also enjoys a successful speaking career that gives him the opportunity to lecture in a number of prestigious schools and universities, as well as health-related institutions. Check Mikhail’s profile on Loop